CIK 0001053691
- Non-accelerated filer
- Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 300645032
- Phone
- +1 617-744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- Open-market buys, last 90 days
- $152,621
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$152,621. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-22 | Winton Matthew Chief Commercial and Business | Grant or award · Stock Option (Right to Buy) | +19,100 | 19,100 | ||
| 2026-02-11 | Winton Matthew Chief Commercial and Business | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-11-18 | Winton Matthew Chief Commercial and Business | Purchase | +1,500 | $7.95 | $12K | 15,000 |
| 2025-11-17 | Winton Matthew Chief Commercial and Business | Purchase | +3,500 | $8.43 | $30K | 13,500 |
| 2025-11-14 | Winton Matthew Chief Commercial and Business | Purchase | +10,000 | $7.57 | $76K | 10,000 |
| 2025-10-06 | Winton Matthew Chief Commercial and Business | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 |
Page 1 of 1 · 6 trades